HP Inc. Appoints Emma Walmsley as Chief Executive Officer
HP INC
Subscribe to track HPQ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š¢ HP Inc. (NYSE: HPQ) has appointed former GSK CEO Emma Walmsley as Chief Executive Officer, effective January 4, 2027.
⢠Leadership Transition: Interim CEO Bruce Broussard will step down on January 3, 2027, and assume the role of Chair of the Board. Current Chair Chip Bergh will remain on the Board. ⢠Board Expansion: Ms. Walmsley will join the Board of Directors, expanding Board seats from 12 to 13. ⢠Compensation Package: Annual base salary of $1,450,000; 200% target annual bonus; FY2027 equity grants totaling $21.5M; $2.5M sign-on cash bonus; and a $30M one-time inducement equity award.
Comprehensive Analysis
Executive Summary
On November 4, 2026, HP Inc. (NYSE: HPQ) filed an 8-K disclosing that its Board of Directors has appointed Emma Walmsley as Chief Executive Officer, effective January 4, 2027.
Key Leadership & Governance Changes
- Chief Executive Officer Appointment: Emma Walmsley (age 57), former CEO of GSK plc (2017ā2025) and current Microsoft director, will succeed Interim CEO Bruce Broussard on January 4, 2027.
- Board Chair Transition: Bruce Broussard will step down as Interim CEO at the end of January 3, 2027, and become Chair of the Board on January 4, 2027. Chip Bergh, current Chair, will step down from the Chair role but remain a director.
- Board Expansion: The Board amended HP's Bylaws to increase the number of authorized directorships from 12 to 13 to seat Ms. Walmsley as a director upon her start date.
Compensation Package
Pursuant to her Offer Letter and Signing Bonus Agreement entered into on November 3, 2026, Ms. Walmsley's compensation includes:
- Base Salary: $1,450,000 annualized.
- Annual Target Bonus: 200% of base salary ($2,900,000 target), prorated for FY2027.
- Sign-On Cash Bonus: $2,500,000 (subject to pro-rata clawback if she voluntarily leaves or is terminated for misconduct within 12 months).
- FY2027 Long-Term Incentive Grants:
- Time-vesting Restricted Stock Units (RSUs) with a grant date value of $6,450,000.
- Performance-adjusted Restricted Stock Units (PARSUs) with a target value of $15,050,000.
- One-Time Inducement Equity Award: $30,000,000 aggregate grant date value ($15,000,000 in RSUs and $15,000,000 in target PARSUs), granted pursuant to NYSE Rule 303A.08.
- Relocation Benefits: Up to $2,500,000 for eligible relocation expenses in her first 12 months.
- Severance Participation: Participation in HP's Severance and Long-Term Incentive Change in Control Plan for Executive Officers (SPEO).
Market & Strategic Impact
Attracting Emma Walmsley represents a major executive hire for HP. Walmsley led GSK through a significant corporate transformation and spinoff during her eight-year tenure as CEO. Her appointment signals HP's commitment to senior operational leadership and strategic repositioning.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
